Sertraline Hydrochloride

盐酸舍曲林

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameSertraline Hydrochloride
Drug Alias NameSertralinum Hydrochloride郁乐复Sertralina Hydrochloride盐酸金曲林Gladem +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsSolid tumoursStress Disorders, Post-TraumaticDepressive Disorder, Major +[37] 
Global Approved IndicationsDepressive DisorderObsessive-Compulsive DisorderAnxiety +[4] 
Approved Indications in ChinaAnxietyDepression
Original Approved Country/TerritoryN/A
Original Approved Date1990/01/01
Country/TerritoryBelgiumCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncAlexandria UniversityViatris Specialty LLC +[5] 
Inactive CompaniesViatrisUniversity Of California San FranciscoUniversity of Texas Southwestern Medical Center +[33] 
Active IndicationsStress Disorders, Post-TraumaticDepressive Disorder, MajorDepressive Disorder +[10] 
Inactive IndicationsSolid tumoursBipolar DisorderAnxiety Disorders +[27] 

Other Information

ATC CodeN06AB06
Related LinksWikipediaDrugBankKEGG